Akari Therapeutics grants director conditional options
The approval condition concerns a proposed increase in shares reserved for issuance under the equity incentive plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Akari Therapeutics Plc director Samir Rashmikant Patel received 6,300 ADSs as RSUs on August 18, 2026, and 2,236 ADSs on October 5, 2026; both were granted in lieu of accrued but unpaid cash retainers. The RSUs and options are subject to forfeiture if shareholders do not approve a proposed equity-plan amendment; RSUs vest in full upon approval. On August 18, Patel received options for 30,000 and 15,000 ADSs, each exercisable at $7.8990 per ADS and expiring August 18, 2036; option vesting also requires approval and continued service.
Insider Trade Summary
Grant/Award: 53,536 shares
Grant/Award
4 txns
Insider
Patel Samir Rashmikant
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | American Depositary Shares representing Ordinary Shares F2, F3 | 2,236 | $7.899 | $18K |
| Grant/Award | Stock Option (Right to Buy) F4 | 30,000 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) F5 | 15,000 | $0.00 | $0.00 |
| Grant/Award | American Depositary Shares representing Ordinary Shares F1, F3 | 6,300 | $7.899 | $50K |
Holdings After Transaction:
Stock Option (Right to Buy) — 45,000 contracts (Direct);
American Depositary Shares representing Ordinary Shares — 12,102 shares (Direct)
Footnotes (5)
- F1. These American Depositary Shares ("ADSs") represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. This RSU grant was approved by the Board of Directors of the Issuer on August 18, 2026, and is subject to forfeiture if shareholder approval of a proposed amendment to the Issuer's equity incentive plan to increase the number of shares reserved for issuance under the plan ("Shareholder Approval") is not obtained. The RSUs will vest in full on the date of Shareholder Approval.
- F2. These ADSs represent RSUs, with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. This RSU grant was approved by the Board of Directors of the Issuer on October 5, 2026, and is subject to forfeiture if Shareholder Approval is not obtained. The RSUs will vest in full on the date of Shareholder Approval.
- F3. This award of RSUs was granted in lieu of accrued but unpaid cash retainers payable to non-execute directors in accordance with the Issuer's remuneration policy.
- F4. On August 18, 2026, the Reporting Person was granted an option to purchase 30,000 ADSs. This option grant is subject to forfeiture if Shareholder Approval is not obtained. The option will vest with respect to 4.17% for each one-month anniversary of August 18, 2026 that has elapsed before the date of Shareholder Approval. The remainder of the option grant will vest in equal, monthly installments beginning on the 18th day of the month subsequent to the month where Shareholder Approval was obtained until fully vested on the two-year anniversary of August 18, 2026, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
- F5. On August 18, 2026, the Reporting Person was granted an option to purchase 15,000 ADSs. This option grant is subject to forfeiture if Shareholder Approval is not obtained. Beginning on the date of Shareholder Approval, this option will vest with respect to 8.33% of the grant on the date of Shareholder Approval plus 8.33% for each one-month anniversary of August 18, 2026 that has elapsed before the date of Shareholder Approval. The remainder of the option grant will vest in equal, monthly installments beginning on the 18th day of the month subsequent to the month where Shareholder Approval was obtained until fully vested on the one-year anniversary of August 18, 2026, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
Key Figures
RSU award: 6,300 ADSs
RSU award: 2,236 ADSs
Option grant: 30,000 ADSs
+4 more
7 metrics
RSU award
6,300 ADSs
Acquired August 18, 2026
RSU award
2,236 ADSs
Acquired October 5, 2026
Option grant
30,000 ADSs
Granted August 18, 2026
Option grant
15,000 ADSs
Granted August 18, 2026
Exercise price
$7.8990 per ADS
Applies to both option grants
Shares represented by each RSU
80,000 ordinary shares
Right to receive shares under each RSU
Option expiration
August 18, 2036
Expiration date for both option grants
Key Terms
restricted stock units, Shareholder Approval, forfeiture, equity incentive plan
4 terms
restricted stock units financial
"These ADSs represent restricted stock units ("RSUs")"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
forfeiture financial
"subject to forfeiture if Shareholder Approval is not obtained"
equity incentive plan financial
"proposed amendment to the Issuer's equity incentive plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What awards did AKTX director Samir Rashmikant Patel receive?
Patel received 6,300 ADSs as RSUs on August 18, 2026, and 2,236 ADSs as RSUs on October 5, 2026. Both RSU awards were granted in lieu of accrued but unpaid cash retainers. Each RSU represents a right to receive 80,000 ordinary shares.
How do the AKTX director's option awards vest?
The 30,000-ADS option vests 4.17% for each one-month anniversary of August 18, 2026, elapsed before Shareholder Approval; the remainder vests in equal monthly installments starting on the 18th day of the month after approval and completes on the two-year anniversary of August 18, 2026. The 15,000-ADS option vests 8.33% on approval plus 8.33% for each elapsed monthly anniversary, then monthly from the 18th day after the approval month through the one-year anniversary. Both require continued service on each vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
